A Cox proportional hazards survival analysis further adjusted for race, age, tumor type, tumor stage and menopausal state showed that TMEM240 promoter hypermethylation was significantly and independently associated with 10-year overall survival (Table 3, p = 0.002). The gene discussed is TMEM240; the disease is neoplasm.